121 related articles for article (PubMed ID: 35213212)
21. Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: a review of the Medicare database.
Sosa R; Li S; Molony JT; Liu J; Stryker S; Collins AJ
Support Care Cancer; 2017 Oct; 25(10):3123-3132. PubMed ID: 28456908
[TBL] [Abstract][Full Text] [Related]
22. Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma.
Li S; Liu J; Bowers C; Garawin TAFS; Kim C; Bensink ME; Chandler DB
Support Care Cancer; 2020 Jan; 28(1):113-122. PubMed ID: 30993450
[TBL] [Abstract][Full Text] [Related]
23. Commentary: Quality nutrition care is integral to the Oncology Care Model.
Arensberg MB; Besecker B; Weldishofer L; Drawert S
Support Care Cancer; 2021 Dec; 29(12):7139-7142. PubMed ID: 34297220
[TBL] [Abstract][Full Text] [Related]
24. Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Halilova KI; Sullivan MM; Rocconi RP; Azuero A; Kvale EA; Huh WK; Partridge EE; Pisu M
J Oncol Pract; 2018 Jun; 14(6):e375-e383. PubMed ID: 28981388
[TBL] [Abstract][Full Text] [Related]
25. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
26. Breast Cancer Stage Is Associated With Exceeding Target Price in the Oncology Care Model.
Thomas RB; Maio V; Chen A; Park S; Waters D; Keith SW; Walsh K; Handley N; Csik VP
JCO Oncol Pract; 2021 Nov; 17(11):e1660-e1667. PubMed ID: 34618553
[TBL] [Abstract][Full Text] [Related]
27. Economic Analysis on Adoption of Biosimilar Granulocyte Colony-Stimulating Factors in Patients With Nonmyeloid Cancer at Risk of Febrile Neutropenia Within the Oncology Care Model Framework.
Wang W; Li E; Campbell K; McBride A; D'Amato S
JCO Oncol Pract; 2021 Aug; 17(8):e1139-e1149. PubMed ID: 33961490
[TBL] [Abstract][Full Text] [Related]
28. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
29. Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia.
Huang Q; Emond B; Lafeuille MH; Gupta D; Lefebvre P; Sundaram M; Mato A
Curr Med Res Opin; 2020 Dec; 36(12):2009-2018. PubMed ID: 33044848
[TBL] [Abstract][Full Text] [Related]
30. A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study.
Bansal A; Sullivan SD; Hershman DL; Lyman GH; Barlow WE; McCune JS; Ramsey SD
J Comp Eff Res; 2017 Jul; 6(5):461-470. PubMed ID: 28686055
[TBL] [Abstract][Full Text] [Related]
31. The Oncology Care Model: Perspectives From the Centers for Medicare & Medicaid Services and Participating Oncology Practices in Academia and the Community.
Kline R; Adelson K; Kirshner JJ; Strawbridge LM; Devita M; Sinanis N; Conway PH; Basch E
Am Soc Clin Oncol Educ Book; 2017; 37():460-466. PubMed ID: 28561660
[TBL] [Abstract][Full Text] [Related]
32. Multiple Myeloma Cost of Care Under the Oncology Care Model: The Influence of High-Cost Therapies.
Theroux H; Williams A; Liu M; Dahl A; Dreyer T; Horvath K; Isola L
JCO Oncol Pract; 2020 Oct; 16(10):e1078-e1084. PubMed ID: 32459566
[TBL] [Abstract][Full Text] [Related]
33. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
[TBL] [Abstract][Full Text] [Related]
34. Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer.
Li S; Liu J; Gong T; Guo H; Gawade PL; Kelsh MA; Bradbury BD; Belani R; Lyman GH
J Geriatr Oncol; 2020 Nov; 11(8):1309-1315. PubMed ID: 32624415
[TBL] [Abstract][Full Text] [Related]
35. Cost variation and savings opportunities in the Oncology Care Model.
Baumgardner J; Shahabi A; Zacker C; Lakdawalla D
Am J Manag Care; 2018 Dec; 24(12):618-623. PubMed ID: 30586495
[TBL] [Abstract][Full Text] [Related]
36. Radiation Therapy Expenditures Through the First 8 Performance Periods of the Oncology Care Model at a Statewide Multispecialty Health System.
De B; Andres G; Bates C; Staren E; Kutscher E; Brooks DJ; Thaker GH; Buscema J; Gin R; Thaker N
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):491-499. PubMed ID: 36427644
[TBL] [Abstract][Full Text] [Related]
37. The Enhancing Oncology Model: Leveraging improvement science to increase health equity in value-based care.
Patel TA; Jain B; Parikh RB
J Natl Cancer Inst; 2023 Feb; 115(2):125-130. PubMed ID: 36245086
[TBL] [Abstract][Full Text] [Related]
38. Prescription of Prophylactic Antiemetic Drugs for Patients Receiving Chemotherapy With Minimal and Low Emetic Risk.
Okuyama A; Nakamura F; Higashi T
JAMA Oncol; 2017 Mar; 3(3):344-350. PubMed ID: 27812688
[TBL] [Abstract][Full Text] [Related]
39. Neutropenia-Associated Outcomes in Patients With Breast Cancer Receiving Myelosuppressive Chemotherapy With Reduced Doses of Pegfilgrastim.
Moore DC; Gebru T; Pellegrino A; Fasan A; Patel J; Ringley JT
J Pharm Pract; 2020 Dec; 33(6):779-783. PubMed ID: 30917723
[TBL] [Abstract][Full Text] [Related]
40. Variations in hospitalization and emergency department/observation stays using the oncology care model methodology in Medicare data.
Li S; Peng Y; Liu J; Li S; Raskin L; Kelsh MA; Zaha R; Gawade PL; Henry D; Lyman GH
Curr Med Res Opin; 2020 Sep; 36(9):1519-1527. PubMed ID: 32715807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
